Treatment of type A insulin resistance with insulin-like growth factor-I

The Lancet

Volumn 341, Issue 8859, 1993, Pages 1536-1537

  Hussain, MehboobA ^a   Froesch, E Rudolf ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN C;

ADULT; CASE REPORT; DRUG THERAPY; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; LETTER; METABOLIC REGULATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; CASE REPORT; FEMALE; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I;

EID: 0027288789     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(93)90674-6     Document Type: Letter

References (5)

1. Lilly lecture: molecular mechanisms of insulin resistance: lessons from patients with mutations in the insulin-receptor gene
2. Recombinant human insulin-like growth factor I (rhIGF-I) reduces hyperglycaemia in patients with extreme insulin resistance
3. Radioimmunological determinations of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic hypoglycemia
4. Insulin-like growth factors